Immunocore IMCR
Valuation
Multiples measured against the stock's own five-year history
Around its usual level · 44th percentile, 5-year average -43.8x
Near the bottom of its 5-year range · 4th percentile, 5-year average 6.1x
#4036 of 5331 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 4th percentile, 5-year average 13.3x
#3497 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 3.69 | – | 6.12 | 4% (cheaper than usual) | #4036 of 5331 (1 = cheapest) |
| PE | -46.78 | -50.27 | -43.81 | 44% (cheaper than usual) | – |
| PS | 3.60 | 3.24 | 13.29 | 4% (cheaper than usual) | #3497 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on IMCR.
Sign in to join the discussion.